Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc (EXPO) is a global leader in multidisciplinary engineering and scientific consulting, addressing complex challenges across industries from transportation to healthcare. This page serves as the definitive source for all company announcements, financial updates, and strategic developments.
Investors and industry stakeholders will find curated EXPO news including earnings reports, partnership announcements, and operational updates. Key updates cover engineering consulting innovations, safety analysis advancements, and regulatory compliance insights that demonstrate the company's technical leadership.
Bookmark this page to track EXPO's progress in solving high-stakes technical challenges through press releases detailing new service offerings, expert commentary on industry trends, and corporate milestones. All content is verified for accuracy and updated systematically to support informed decision-making.
Exponent Inc (Nasdaq: EXPO) has scheduled its First Quarter Fiscal Year 2025 financial results announcement for May 1, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.
CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended April 4, 2025. Investors can access the call through dial-in numbers (844) 481-2781 or (412) 317-0672.
A live and archived webcast will be available through the company's Investor Relations website. A replay of the call will be accessible until May 8, 2025, via (877) 344-7529 or (412) 317-0088 with passcode 8332346#.
Exponent (NASDAQ: EXPO) has announced a 7.1% increase in its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The dividend will be paid on March 21, 2025, to stockholders of record as of March 7, 2025.
This marks the 12th consecutive year of dividend increases for the company. Exponent maintains a quarterly dividend schedule, with payments in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan highlighted the company's commitment to shareholder value, emphasizing their diverse services portfolio and aligned operating model as key factors positioning them for market growth.
Exponent (NASDAQ: EXPO) reported strong Q4 and fiscal year 2024 results, with total Q4 revenues increasing 11.3% to $136.8 million and revenues before reimbursements rising 8.7% to $123.8 million. Q4 net income grew to $23.6 million ($0.46 per diluted share), up from $20.9 million ($0.41 per diluted share) in Q4 2023.
For fiscal year 2024, total revenues increased 4.1% to $558.5 million, with net income reaching $109.0 million ($2.11 per diluted share). The company achieved growth across both proactive and reactive services, particularly in consumer electronics, utilities, and medical devices. EBITDA margin improved to 28.4% of revenues before reimbursements.
The company increased its quarterly dividend from $0.28 to $0.30 and ended the year with $258.9 million in cash. Looking ahead to 2025, Exponent expects low single-digit revenue growth despite a 5-6% headwind in technical full-time-equivalent employees.
Exponent (NASDAQ: EXPO) has scheduled its Fourth Quarter and fiscal year 2024 financial results announcement for Thursday, February 6, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.
CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended January 3, 2025. Investors can access the live call through designated phone numbers or view the webcast through Exponent's Investor Relations website. A telephonic replay will be available until February 13, 2025.
Exponent (NASDAQ: EXPO) reported Q3 2024 financial results with flat revenues before reimbursements at $125.1 million, while total revenues increased 2% to $136.3 million. Net income grew 6% to $26.0 million ($0.50 per diluted share), and EBITDA margin expanded by 100 basis points to 28.6%. The company saw healthy rebound in consumer electronics sector, offset by challenges in chemicals. Year-to-date results showed 3% growth in revenues before reimbursements to $394.7 million, with net income of $85.4 million ($1.66 per diluted share). The company maintained revenue guidance and raised margin guidance for full-year 2024.
Exponent (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share for Q4 2024, payable on December 20, 2024, to stockholders of record as of December 6, 2024. The company maintains its quarterly dividend schedule in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholders, highlighting their diverse services portfolio and aligned operating model as key factors in capturing market demand and delivering long-term value.
Exponent, Inc. (Nasdaq: EXPO) has announced it will report its Third Quarter of fiscal year 2024 financial results on Thursday, October 24, 2024, after market close. The results will cover the period ended September 27, 2024. Following the release, the company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the business and financial results.
The call will be led by Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, Executive VP and CFO. Investors can join the live call at (844) 481-2781 or (412) 317-0672. A live and archived webcast will be available from the Investor Relations section of Exponent's website. A telephonic replay will be accessible until October 31, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 1389454#.
Exponent, Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share of common stock, payable on September 20, 2024, to stockholders of record as of September 6, 2024. The company maintains its practice of paying quarterly dividends in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, emphasized Exponent's commitment to shareholders through this dividend, citing strong market drivers and strategic positioning as enablers of sustainable long-term growth. Future dividend declarations remain subject to the Board of Directors' final determination.
Exponent, Inc. (Nasdaq: EXPO) reported its Q2 2024 financial results, showing flat total revenues at $140.5 million and a 2% increase in revenues before reimbursements to $132.4 million. Net income grew 14% to $29.2 million, or $0.57 per diluted share. EBITDA increased to $39.9 million, representing 30.2% of revenues before reimbursements. The company's engineering and scientific segment, accounting for 84% of revenues, grew 4% in Q2. Despite challenges in consumer electronics and chemicals sectors, Exponent saw growth in transportation, utilities, and medical device sectors. The company raised its full-year 2024 guidance, expecting low to mid-single digit growth in revenues before reimbursements and EBITDA to be 27.5% to 28.0% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) will announce its financial results for the second quarter of fiscal year 2024 on July 25, 2024, after the market closes. The results cover the period ending June 28, 2024. On the same day, CEO Dr. Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast at 4:30 p.m. ET to discuss the company's business and financial performance. Interested parties can join the live call by dialing (844) 481-2781 or (412) 317-0672, and a replay will be available until August 1, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 2296670#. Both the live and archived webcast will be accessible via Exponent's Investor Relations webpage.
